BioSpace News Archive

Policy

Protalix BioTherapeutics Receives Positive Opinion for Orphan Designation for PRX-102 for the Treatment of Fabry Disease in the European Union

In its official opinion letter, the COMP explained that Protalix has established that although satisfactory methods of treatment of Fabry disease have been authorized in the European Union, PRX-102 will be of significant benefit to those affected by Fabry disease.

November 13, 2017
·
7 min read
BioMidwest

3M Announces Upcoming Investor Events

These events will be webcast live, and replays of each will be available on 3M’s Investor Relations website at http://investors.3M.com.

November 13, 2017
·
1 min read
Pharm Country

Medifirst Solutions to Introduce the Time Machine Laser at the Greater New York Dental Meeting at the Javits Convention Center

Medifirst Solutions announce that it is exhibiting at the Greater New York Dental Meeting, a six-day event being held from November 24th to the 29th 2017 at the Jacob K. Javits Convention Center in New York City.

November 13, 2017
·
3 min read
Business

AC Immune SA Reports Third Quarter 2017 Financial Results and Corporate Update

AC Immune generated revenues of CHF 1.0 million in the three months ended September 30, 2017, a decrease of CHF 0.3 million over the comparable period in 2016.

November 13, 2017
·
12 min read
Inventiva to Present at Two Upcoming Investor Conferences

Inventiva today announced that Frédéric Cren, CEO of Inventiva, will present at two upcoming investor conferences.

November 13, 2017
·
2 min read
Business

Kamada Reports Financial Results for Third Quarter and First Nine Months of 2017

Total revenues for first 9 months of 2017 were $67.1 million, a 26% Increase .

November 13, 2017
·
18 min read
Business

Lilly Appoints Philip Johnson to Senior VP and Treasurer

Eli Lilly today announced Philip Johnson has been appointed to senior VP, Finance, and treasurer effective January 1, 2018.

November 13, 2017
·
1 min read
Business

Jounce Therapeutics Reports Third Quarter 2017 Financial Results

Jounce has narrowed its financial guidance previously provided for the full year 2017.

November 13, 2017
·
11 min read
Business

Fennec Provides Business Update And Reports Third Quarter 2017 Results

Cash and cash equivalents were $9,688 at September 30, 2017 and $3,926 at December 31, 2016.

November 13, 2017
·
10 min read
Pharm Country

Amarin Corporation: Real-World Data Analysis Shows That High Triglyceride Levels Are Associated With Increased Cardiovascular Events and Medical Costs

The analysis was presented at the 2017 American Heart Association (AHA) Scientific Sessions in Anaheim, CA.

November 13, 2017
·
9 min read